David R. Bauer
Lawyers
Filters
GSK exclusive license agreement for HS-20093 with Hansoh Pharma
We advised GSK on the transaction
Merit Medical Systems $747.5 million convertible senior notes offering
The 3% convertible senior notes are due 2029
Integral Ad Science $152.8 million secondary offering
The stock is listed on the Nasdaq Global Select Market
Smith+Nephew acquisition of CartiHeal
We are advising Smith+Nephew on the acquisition
Bristol Myers Squibb $4.5 billion notes offering
The investment-grade offering comprised four tranches
NeuroPace $50 million at-the-market offering
The stock is listed on the Nasdaq Global Market
Forbion European Acquisition $138 million combination with enGene
We advised Forbion European Acquisition on its de-SPAC transaction
GSK exclusive license agreement for HS-20089 with Hansoh Pharma
We advised GSK on the transaction
GSK collaboration extension and new data licensing agreement with 23andMe
We advised GSK on the transaction
IDEAYA Biosciences $143.8 million equity offering
The common stock is listed on the Nasdaq Global Select Market